Ctnnb1 Syndrome clinical trials

Explore recruiting ctnnb1 syndrome clinical trials.

Recruiting ctnnb1 syndrome studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ctnnb1 Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

GAIN-CTNNB1: A Phase I/II open-label trial to evaluate the safety, tolerability, and preliminary efficacy of a single intracerebroventricular administration of an AAV9-based gene replacement therapy in paediatric patients with CTNNB1 syndrome

Slovenia

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Ctnnb1 Syndrome trials by city

Ctnnb1 Syndrome in Toronto Ctnnb1 Syndrome in Vancouver Ctnnb1 Syndrome in Montreal Ctnnb1 Syndrome in Calgary Ctnnb1 Syndrome in Edmonton Ctnnb1 Syndrome in Ottawa Ctnnb1 Syndrome in Winnipeg Ctnnb1 Syndrome in Quebec City Ctnnb1 Syndrome in Hamilton Ctnnb1 Syndrome in Kitchener Ctnnb1 Syndrome in London Ctnnb1 Syndrome in Halifax Ctnnb1 Syndrome in New York Ctnnb1 Syndrome in Los Angeles Ctnnb1 Syndrome in Chicago Ctnnb1 Syndrome in Houston

Ctnnb1 Syndrome clinical trials

Recruiting ctnnb1 syndrome studies right now

Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome

Also recruiting in Europe

GAIN-CTNNB1: A Phase I/II open-label trial to evaluate the safety, tolerability, and preliminary efficacy of a single intracerebroventricular administration of an AAV9-based gene replacement therapy in paediatric patients with CTNNB1 syndrome

Ctnnb1 Syndrome trials by city

Other conditions